Clinical Trial Update: Topical Brimonidine to Reduce Inflammation After IPL-treatment in Patients With Facial Telangiectasias [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating topical brimonidine to reduce inflammation after IPL treatment for facial telangiectasias has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facial Telangiectasia
• Telangiectasias

Drugs mentioned

• Brimonidine (brimonidine)

Snippet

Sponsor: Merete Haedersdal | Conditions: Telangiectasias | Phase 4 | Status: COMPLETED